WHO: The delta variant is the fittest coronavirus strain.

I agree 100%. A triple threat: more transmissible, more serious disease, & able to evade one dose of vaccine. The devastation it caused in India shook us.

Which is why we plead:
#GetFullyVaccinated
Here is what the WHO has said. google.com/amp/s/www.busi…
The risk of getting COVID is much lower after full vaccination. 88% efficacy with Pfizer. 60% efficacy with Astra Zeneca.

The risk of getting seriously ill is also much lower. 94% efficacy with Pfizer. 92% with Astra Zeneca.
In the UK, some developed COVID despite being fully vaccinated. In them, the death rate was 0.6%. However, most fully vaccinated were elderly, and the expected mortality rate in this age group was probably 5-10 times higher without vaccination.

See informative thread @DrEricDing

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vincent Rajkumar

Vincent Rajkumar Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @VincentRK

18 Jun
A U turn in the UK due to the delta COVID variant. #GetVaccinated
For those reminding me that we should worry about deaths not cases: I said the same. Then the delta variant & India crisis happened. I still think the vaccines we have will do the job. But we need to improve vaccination rates coz 44% of population fully vaccinated is not enough.
If you are fully vaccinated, you are protected. Tell your friends to get vaccinated if they haven't already.

If you are eligible and have not been vaccinated, get vaccinated. Don't take chances with this one. Not worth it.
Read 5 tweets
16 Jun
The RECOVERY trial for COVID is the trial that keeps giving. Has already identified 3 life-saving treatments. Found 6 treatments to be not useful.

Publicly funded. Clinically relevant

Why are we not able to do such trials in the US?

1) Poor funding for RCTs
2) Too many cooks
The RECOVERY trial in reality is multiple randomized trials in one. Each trial will cost an order of magnitude more to run in the US. We simply do not have the public funding to support RCTs. Which is a tragedy given how much we spend, and how much we can gain.
@NIH @NIHDirector
I have led several RCTs. Some through NIH. Some through Pharma.

The NIH trials were like pulling teeth. The Pharma trials were far easier to pull off. So besides lack of funding we also have a process problem for publicly funded trials. See below.
Read 4 tweets
14 Jun
Requesting FDA & CDC to provide guidance on these 2 questions that many concerned citizens are asking

1. Should patients on chemotherapy/immunosuppression get neutralizing antibodies checked, and if negative get a booster?

2. Should people who got single dose J&J get a booster?
We have data that neutralizing antibody levels are predictive of protection.
We also have data that one dose of vaccine is only 33% effective against symptomatic COVID cause by delta variant (AZ or Pfizer). Versus 51% against alpha.

2 doses Pfizer 88% against delta versus 93% against alpha.

2 doses AZ 60% (delta) vs 66% (alpha)
medrxiv.org/content/10.110…
Read 5 tweets
12 Jun
For those of you interested in multiple myeloma, here is a brief state of the science for treatment.

1/ For newly diagnosed patients, triplets, VRd or DRd, are the standard of care. Current RCTs are examining if we can improve outcome using quadruplets. Eg. PERSEUS trial.
2/ In newly diagnosed myeloma, another question given the cost & potential toxicity of quadruplets is to start with a triplet, and based on MRD status identify patients who need 4 drugs versus this who do equally well with 3 drugs. Eg: EQUATE trial. @myelomaMD @mtmdphd @eaonc
3/ Auto stem cell transplant is still standard of care for eligible patients. Current data indicate overall survival is similar whether the transplant is done early or delayed. But for many reasons we prefer early transplant for most patients.
Read 7 tweets
11 Jun
The delta variant is the triple threat I have talked about. I am not saying this lightly. I take no pleasure in alarming people. It's just the facts after 2 months of being closely involved with the India COVID crisis. This is not last years COVID. Get vaccinated.
The message is not alarm. The message is that there is an easy solution that works. #GetVaccinated
Read 5 tweets
10 Jun
When the FDA approves a drug, it is not only approving the drug. Its actions provide prolonged monopoly protection to a drug in a country where the seller can set whatever price they want, the buyer cannot negotiate price, and competitors will face more severe barriers to entry
If like other Western countries we had a 2-step process for prescription drugs: regulatory approval followed by value based pricing determination, I would have less problem with an FDA that is more lenient.
If like other countries barriers to market entry to competition are not so hard, then I would have less problem with an FDA that is more lenient.
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(